insulin
-
Novo Nordisk to offer free, one-time supply of insulin to people in immediate need
Jan 4, 2020Novo Nordisk said on Thursday it would offer free, one-time supply of insulin to people in immediate need and at risk of rationing the medication, the rising price of which has attracted fierce criticism from lawmakers... -
Global study predicts more than 20% rise in insulin use by 2030
Nov 21, 2018The amount of insulin needed to effectively treat type 2 diabetes will rise by more than 20% worldwide over the next 12 years, but without major improvements in access, insulin will be beyond the reach of... -
Novo Nordisk’s new-generation basal insulin Tresiba® approved in China
Sep 27, 2017News Hour: Novo Nordisk today announced that the China Food and Drug Administration (CFDA) has approved Tresiba® (insulin degludec) for the treatment of diabetes in China. Tresiba® is a new-generation, once-daily basal insulin with an ultra-long duration of action which allows... -
Sanofi receives CHMP recommendation for the approval of insulin Lispro Biosimilar
May 25, 2017News Hour: Sanofi announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the marketing authorization of Insulin lispro Sanofi® (insulin lispro 100... -
Living with one’s spouse halves the risk of being overweight among patients with type 2 diabetes
Sep 17, 2016News Hour: When a patient with type 2 diabetes lives with their spouse, their risk of being overweight halves compared with those patients with type 2 diabetes who are single. Among patients with type 2 diabetes...
